Outcome | Control group (n=6) | Intervention group (n=6) | Risk differencec (Control-intervention) (95 % CI) | p-value |
---|---|---|---|---|
Primary outcome | ||||
 PPH Hb diffa ≥2g/dl (sd) | 18.5 % (5.9) | 11.4 % (8.4) | 7.1 % (-3.1 % to 17.3 %) | 0.14 |
 PPH Hb diffb ≥2g/dl (sd) | 15.0 % (4.3) | 11.1 % (3.0) | 3.9 % (-1.5 % to 9.3 %) | 0.12 |
Secondary outcomes | ||||
 Postpartum anaemia (sd) | 43.3 % (10.0) | 41.3 % (11.0) | 2.0 % (-2.4 % to 6.4 %) | 0.30 |
 Health facility births (sd) | 87.5 % (7.3) | 85.4 % (9.3) | 2.1 % (-1.4 % to 5.6 %) | 0.19 |
 Uterotonic use at birth (sd) | 80.4 % (12.6) | 91.4 % (7.0) | −11.0 % (-25.7 % to 3.6 %) | 0.11 |
 Fever & shivering (sd) | 14.9 % (3.4) | 22.2 % (5.3) | −7.2 % (-11.1 % to -3.7 %) | 0.005 |